Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis

Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis

Patients with sepsis and a pre-existing diagnosis of insulin-treated diabetes (ITD) may show a different relationship between hospital mortality and highest glucose levels and glycemic variability in the first 24 hours than... read more

A comparison of two insulin infusion protocols in the ICU by continuous glucose monitoring

A comparison of two insulin infusion protocols in the ICU by continuous glucose monitoring

The Yale protocol provided better average glycemia, more time spent in normoglycemia, less time in hypoglycemia, and less glycemic variability than the Leuven protocol, but was not independently associated with strict glycemic... read more

Hyperglycaemia in Critically Ill Patients

Hyperglycaemia in Critically Ill Patients

There is an ongoing debate regarding the efficacy of glycaemic control in critically ill patients. Here we briefly highlight the key function of elevated glucose in critically ill patients, namely, to enable elevation of... read more

Anabolic and Anticatabolic Agents in Critical Care

Anabolic and Anticatabolic Agents in Critical Care

Profound metabolic derangements occur in critically ill patients; this hypermetabolic response is a major contributor to adverse outcomes. Despite the pharmacological therapies currently available to counteract this devastating... read more

Better glycemic control with continuous glucose monitoring

Better glycemic control with continuous glucose monitoring

This randomized clinical trial compares the effects of continuous glucose monitoring vs conventional treatment for glycemic control in adult patients with type 1 diabetes treated with multiple daily insulin injections.... read more

Disease Causation Index Established By New Mathematical Model

Disease Causation Index Established By New Mathematical Model

Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment. By analysing... read more

Diabetes monitoring breathalyzer developed

Diabetes monitoring breathalyzer developed

A new hand-held breathalyzer that allows individuals to easily assess their blood glucose levels has been developed. The device informs the user bout diabetes risk and it differs from a medical device we reported on earlier... read more

Low Blood Glucose Levels In Hospitalized Patients Linked To Increased Mortality Risk

Low Blood Glucose Levels In Hospitalized Patients Linked To Increased Mortality Risk

Mortality risk was higher in insulin-treated patients with moderate hypoglycemia (40-70 mg/dL), compared to patients without insulin treatment with similar glucose values.... read more

Insulin resistance reversed by removal of protein

Insulin resistance reversed by removal of protein

By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of... read more

FDA approves automated insulin delivery device for type 1 diabetes

FDA approves automated insulin delivery device for type 1 diabetes

The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.... read more

Artificial pancreas could save lives

Artificial pancreas could save lives

An Asheville doctor-and-son team have an idea they say could save at least 100,000 lives a year. Leon and Jeremy DeJournett have patented an artificial pancreas, a system that uses a form of artificial intelligence to ensure... read more